Sequencing analysis of OMI/HTRA2 shows previously reported pathogenic mutations in neurologically normal controls

101Citations
Citations of this article
54Readers
Mendeley users who have this article in their library.
Get full text

Abstract

A novel heterozygous non-synonymous mutation and a novel polymorphism in OMI/HTRA2 locus have been associated with Parkinson's disease (PD) in a German population. In an attempt to replicate these results in an independent population, we analyzed the entire coding region of OMI/ HTRA2 in a series of 644 North American PD cases with both young- and late-onset disease and in 828 North American neurologically normal controls. Our results show that neither of the variants previously related to PD were associated with PD in our cohort and that the risk variants were present in neurologically normal controls. © The Author 2008. Published by Oxford University Press. All rights reserved.

Cite

CITATION STYLE

APA

Simón-Sánchez, J., & Singleton, A. B. (2008). Sequencing analysis of OMI/HTRA2 shows previously reported pathogenic mutations in neurologically normal controls. Human Molecular Genetics, 17(13), 1988–1993. https://doi.org/10.1093/hmg/ddn096

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free